PhD Matija Rijavec

PhD Matija Rijavec
no.: 29300 source: ARIS

researcher – active in research organisation
  matija.rijavecat signklinika-golnik.si
Edit
Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   
3.05.00  Medical sciences  Human reproduction   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
1,364.44
A''
189.59
A'
552.45
A1/2
654.95
CI10
1,523
CImax
198
h10
23
A1
4.58
A3
0.04
Data for the last 5 years (citations for the last 10 years) on April 16, 2026; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 98  1,712  1,491  15.21 
Scopus 86  1,944  1,711  19.9 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 2004 
Doctoral degree  Ph. D.   Microbiology  SI University of Ljubljana, Biotechnical Faculty 2010 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  University Clinic of Respiratory and Allergic Diseases  Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Slovene)  2/1/2007    Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-70144  Development of new peptide therapies for the treatment of autoimmune and allergic diseases   3/1/2026 - 2/28/2029  PhD Peter Korošec   3,734 
2. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   10/1/2023 - 9/30/2026  PhD Katja Uršič Valentinuzzi   3,567 
3. J3-50114  Whole genome approach to decipher the genetic basis of anaphylaxis   10/1/2023 - 9/30/2026  PhD Matija Rijavec   3,926 
4. J3-4516  Neoantigens in non small cell lung cancer   10/1/2022 - 9/30/2025  PhD Julij Šelb   2,471 
5. J3-3072  Heritable risk for anaphylaxis associated with the increased germline copy number of α-tryptase-encoding sequences at TPSAB1   10/1/2021 - 9/30/2024  PhD Peter Korošec   3,896 
6. J3-2532  Bradykinin-mediated angioedema: Novel biomarkers and genetic predisposition   9/1/2020 - 8/31/2023  PhD Matija Rijavec   4,103 
7. J3-6787  Ugotavljanje bolnikove kompletne specifične IgE alergogene aktivnosti z uporabo kombinacije rekombinantnih alergenov in multiparameterske analize aktivacije bazofilcev (Slovene)   11/1/2014 - 10/31/2017  PhD Peter Korošec   3,604 
8. J3-3626  Genetic factors involved in imunoregulatory cells deficiency in diseases with expansion of CD4-positive Th-1 biased T cell response   5/1/2010 - 4/30/2013  PhD Peter Korošec   3,709 
9. J3-2234  PREOBLIKOVANJE DIHALNIH POTI - ANGIOGENEZA PRI RINITISU IN ASTMI IN VPLIV VEGF POLIMORFIZMOV (Slovene)   5/1/2009 - 4/30/2012  PhD Peter Korošec   3,891 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. I0-0062  Infrastrukturna dejavnost KLINIKA GOLNIK (Slovene)   1/1/2022 - 12/31/2027 PhD Peter Korošec   2,374 
2. P3-0360  Slovenian network of allergy and asthma: from epidemiology to genetics   1/1/2019 - 12/31/2027 PhD Mitja Košnik   7,751 
3. P3-0360  Slovenian network of allergy and asthma: from epidemiology to genetics   1/1/2013 - 12/31/2018 PhD Mitja Košnik   9,022 
Confirmation required
Views history
Favourite